Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 25/02/20 → 24/02/25 |
Keywords
- clinical trial
- phase 1 study
- treatment efficacy
- lymphoma
- leukemia
Clinical Trial Phase
- Phase I
A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 inhibitor BGB-11417 in Patients with Mature B-Cell Malignancies
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research